Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Immunization for Respiratory Syncytial Virus-Promises and Pitfalls
This editorial discusses the potential benefits and challenges of vaccines for the respiratory syncytial virus (RSV). It explains how RSV affects children and older adults, …
Pricey or Priceless: Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Prevention in Infants
2024
· University of Antwerp
This comment discusses the cost-effectiveness of preventing RSV in infants. It compares different strategies, like using monoclonal antibodies (nirsevimab) and a maternal vaccine (MV). It …
Introduction to This JPIDS Supplement: All Infant Protection Against Serious RSV Disease
This article describes the challenges and advancements in protecting infants from serious RSV disease. It highlights the unpredictability of RSV, especially during the COVID-19 pandemic, …
Single-Dose Nirsevimab Prevents RSV Infection
This article commentary discusses a study on nirsevimab, a single-dose treatment that helps prevent RSV infections in preterm infants. Conducted across 164 sites in 23 …
Parent Perspectives on Nirsevimab for Their Newborn
2024
· Yale School of Medicine,
· Yale University
This article explores how parents feel about using nirsevimab for their newborns. Nirsevimab is a medicine that helps protect babies from RSV, a common virus …
Clinical Progression Scale-Pediatrics: A Potential Metric of Respiratory Syncytial Virus Severity and Progression in Children
This editorial comments on a study titled "Assessing Clinical Improvement of Infants Hospitalized for Respiratory Syncytial Virus–Related Critical Illness" by Leland et al. 2025. It …
RSV Immunization Uptake Among Infants and Pregnant Persons — Wisconsin, October 1, 2023 - March 31, 2024
This short communication looks at new prevention strategies, such as the maternal RSVpreF vaccine and nirsevimab monoclonal antibody for prevention of RSV among infants. It …
RSV Prevention in Infants: Promising Products, But at What Cost?
This commentary is related to two studies on the cost-effectiveness of maternal vaccination and nirsevimab for infants for the prevention of respiratory syncytial virus (RSV). …
Respiratory Diseases Surge While Immunizations Wane
2025
· Children's Hospital Colorado
The newsletter article highlights a rise in respiratory diseases like RSV, COVID-19, and influenza in Colorado due to low vaccination rates. It describes how children …
Digital Toolkit for the Maternal RSV Vaccine
This is a digital toolkit for the maternal RSV vaccine, which helps protect babies from severe RSV disease. It includes decision guides and videos about …